Home/Pipeline/Amoxicillin 500 mg

Amoxicillin 500 mg

Bacterial Infections

CommercialActive

Key Facts

Indication

Bacterial Infections

Phase

Commercial

Status

Active

Company

Laboratorios Saval

About Laboratorios Saval

Latin‑American generic drug manufacturer with GMP‑certified plants and regional distribution network.

View full company profile

Therapeutic Areas

Cardiovascular Infectious Diseases Pain Management Respiratory Central Nervous System

Other Bacterial Infections Drugs

Drug	Company	Phase	Status
Generic Portfolio Expansion - Anti-infectives	Alkaloid AD Skopje	Regulatory Submission	Active
Vibativ® (telavancin)	Cleo Life Sciences	Approved	Supported late-stage development & NDA
Penicillin V API	Biotika	Commercial	Active
Sterile Injectable Antibiotics Portfolio	Steripharma	Approved	Active
Oral Antibiotic	Dawah Pharmaceuticals	ANDA Filed/Pre-approval	Active
XAB05/XAB06	Xenothera	Preclinical	Active
Antibacterial Program	Prosetta Biosciences	Preclinical	Active
Novel Antibiotic Class 1	ArrePath	Pre-clinical	Active
Novel Antibiotic Class 2	ArrePath	Pre-clinical	Active
Amoxicillin/AmoxiClav Generics	Puren Pharmaceuticals	Approved	Active
Ready-to-Use Antibiotics in Bags	Galenica Senese	Commercial	Active
Legrand‑AmoxClav	Laboratorios Legrand	Commercial	Active